The p53-targeted kinases casein kinase 1d (CK1d) and casein kinase 1e (CK1e) have been proposed to be involved in regulating DNA repair and chromosomal segregation. Recently, we showed that CK1d localizes to the spindle apparatus and the centrosomes in cells with mitotic failure caused by DNA-damage prior to mitotic entry. We provide here evidence that 3-[(2,4,6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261), a novel inhibitor of CK1d and CK1e, triggers the mitotic checkpoint control. At low micromolar concentrations IC261 inhibits cytokinesis causing a transient mitotic arrest. Cells containing active p53 arrest in the postmitotic G1 phase by blockage of entry into the S phase. Cells with non-functional p53 undergo postmitotic replication developing an 8N DNA content. The increase of DNA content is accompanied by a high amount of micronucleated and apoptotic cells. Immun¯uorescence images show that at low concentrations IC261 leads to centrosome ampli®cation causing multipolar mitosis. Our data are consistent with a role for CK1d and CK1e isoforms in regulating key aspects of cell division, possibly through the regulation of centrosome or spindle function during mitosis. Oncogene (2000) 19, 5303 ± 5313.
Introduction
Casein kinase 1 (CK1) contain a family of highly related, constitutively active serine/threonine protein kinases (reviewed in Christenson et al., 1997; Gross and Anderson, 1998) . CK1 is ubiquitously expressed in eukaryotes. Mammalian family members comprise three alternatively spliced a isoforms as well as b, g1, g2, g3, d and e isoforms (Fish et al., 1995; Graves et al., 1993; Rowles et al., 1991; Zhai et al., 1995) . These isoforms share a high degree of similarity within their protein kinase domains. For example CK1d and CK1e are 98% identical in this region (Fish et al., 1995; Graves et al., 1993) , but show considerable variation in the presence, length and primary structure of the Cterminal non-catalytic domain . These variable C-terminal domains are responsible for substrate speci®city of the dierent isoforms (Cegielska et al., 1998; Graves and Roach, 1995) , and are involved in the regulation of the interaction with other proteins, and/or subcellular structures. Phosphorylation (Cegielska et al., 1998) and perhaps dimerization in the case of CK1d (Longenecker et al., 1998) are additional mechanisms that regulate CK1 activity, speci®city, and subcellular localization. The list of known substrates of the CK1 family is still increasing, and so far includes cytoskeletal proteins such as spectrin, troponin, myosin and tau (Simkowski and Tao, 1980; Singh et al., 1983 Singh et al., , 1995 , and transcriptional components such as RNA polymerases I and II, SV40 T antigen and CREM (Dahmus, 1981; de Groot et al., 1993; GraÈ sser et al., 1988) .
Both, CK1d and CK1e, have been reported to phosphorylate p53 in vitro and in cultured cells (Knippschild et al., 1997; Milne et al., 1992b) . The residues phosphorylated by these isoforms, and by high levels of CK1a in vitro, are serines 4, 6 and 9 in murine p53 Knippschild et al., 1997; Milne et al., 1992a) , and threonine 18 in human p53 (Dumaz et al., 1999; Sakaguchi et al., 2000) . However, the eect of phosphorylation by these two kinases on p53 activity is not yet known, neither is it clear what the biological signi®cance of the p53-CK1 interaction might be.
Real advances in our understanding of the biology of CK1 have been provided by a number of genetic analyses in yeasts. The S. cerevisiae hrr25 gene encodes a homologue of mammalian CK1d and CK1e; hrr25 mutants show sensitivity to DNA damage and are defective in nuclear segregation and meiotic division (Hoekstra et al., 1991) . CK1d and CK1e, but not CK1a, can complement hrr25 mutations in yeast, suggesting that the mammalian and yeast proteins may have functional similarity Graves et al., 1993) . In S. pombe the homologous hhp1 and hhp2 genes may play similar roles to hrr25 and deletion of these genes generates large multinucleated cells (Dhillon and Hoekstra, 1994) .
Additional evidence links CK1 function with chromosomal maintenance. For example, DMCK1 (the homologue of CK1a in D. melanogaster), is activated following DNA damage and relocates to the nucleus (Santos et al., 1996) , while mammalian CK1a is located at the mitotic spindle and the Oncogene (2000) 19, 5303 ± 5313 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc *Correspondence: U Knippschildcentrosomes in both mouse ®broblasts and oocytes (Brockman et al., 1992; Gross et al., 1997) . Recently we showed that CK1d is recruited to the mitotic spindle and the centrosomes following treatment with etoposide or g-irradiation in rodent cells (Behrend et al., 2000) . The radiation treatment prior to mitosis frequently leads to centrosome overduplication and multipolar spindle (Behrend et al., 2000; Sato et al., 2000) , morphologies that are known to activate the mitotic checkpoint. Thereby, the recruitment of CK1d to the spindle/centrosome in aberrant mitotic cells may be interconnected with a mitotic checkpoint signal.
This view is also supported by the close link of CK1d to the tumor suppressor protein p53 (s. above). Next to its role in DNA-damage checkpoint control (Agarwal et al., 1995; Kastan et al., 1991) p53 also has been shown to participate in the response to aberrant mitosis (Cross et al., 1995; Lanni and Jacks, 1998; Minn et al., 1996; Wahl et al., 1996b) . It is now generally believed that p53 is not a key component of the spindle assembly checkpoint itself but prevents transition of abnormal postmitotic cells from G1 to S phase (Kahn et al., 1998; Lanni and Jacks, 1998) . However, the nature of the signaling mechanism(s) through which p53 senses the damage of cells treated with spindle drugs is not known.
In the present paper we describe the eect of an ATP-competitive inhibitor IC261 with dierential activities among CK1 isoforms (Mashhoon et al., 2000) in a wild-type or mutant p53 containing tumor cell line (MethAtsp53 cells) as well as in p53 wild-type (+/+ MEFs), p53 plus-minus (+/7 MEFs) and p53-null mouse embryo ®broblasts (7/7 MEFs). After p53-independent mitotic delay IC261 induces a p53-dependent G1 arrest. In cells lacking active p53 we observed endoreduplication, resulting in an 8N DNA content, coupled with morphological changes characterized by large¯attened cells predominantly containing micronuclei. Immuno¯uorescence microscopy of IC261-treated mitotic cells showed centrosome overduplication and multipolar mitosis. We conclude that CK1d/e activity is indispensable for an ordered mitotic progression probably by regulating centrosome and/or spindle functions.
Results

Effects of IC261 on cell cycle distribution and cell survival in murine tumor cell lines
In order to determine whether CK1d and CK1e activity is required for normal cell cycle progression we have made use of the novel, well-characterized inhibitor IC261. IC261 (Icos Corp., USA) selectively inhibits CK1 compared to other protein kinases by an ATP-competitive mechanism. Moreover, IC261 shows an order of magnitude higher selectivity for CK1d and CK1e over other CK1 isoforms. The basis of CK1 speci®city has been established at 2.8 A resolution by X-ray crystallography (Mashhoon et al., 2000) .
The eects of IC261 in the low micromolar range on cell cycle distribution of primary mouse embryo ®broblasts (MEFs) (2. passage) with dierent p53 status (p53+/+, p53+/7 and p537/7) were measured by¯ow cytometry (Figure 1a) . The cell cycle distribution pro®les indicate that, 12 h after exposure to the drug, the MEFs arrested with a 4 N DNA content, independently of the p53 status. At subsequent timepoints, the pro®les show distinct dierences depending on the p53 status of the cells. p53+/+ cells predominantly remain in the 4 N arrest with only 22% of the cells with a higher DNA content while p53+/7 (30%) and in particular p537/7 cells (57.5%) developed a larger 8 N population. The increase of a 8 N population in 7/7 MEFs was accompanied by a strong decrease in the proportion of cells with a 4 N content to 21.6% after 48 h.
In all investigated MEFs the treatment with IC261 increases the incidence of a sub-G1 fraction in the¯ow cytometry pro®les indicating a possible apoptotic eect of the kinase inhibitor IC261. To evaluate the cytotoxic eect of IC261 on cultured cells we performed a combined PI-AnnexinV binding procedure (Vermes et al., 1995) . MEFs were incubated with 1 mM IC261 and were assayed for a necrotic (PI+/FITC+) or an apoptotic (PI7/FITC+) subfraction (Figure 1b) . In the untreated controls we found almost exclusively viable cells (PI7/FITC7); the amount of apoptotic cells in MEFs of all three genotypes were below 4%. The application of IC261 increases the amount of apoptotic cells after 3 days up to 40% in 7/7 MEFs whereas only 23.4% of +/7 MEFs and only 15.2% of +/+ MEFs show AnnexinV binding. The quantity of non-binding PI`stained cells' indicating a possible necrotic eect were negligible in all performed experiments. The diagram following the progression of apoptosis shows an increasing subpopulation of apototic cells in all three MEFs up to the fourth day of IC261 treatment but with a slightly higher amount in +/7 MEFs and markedly higher amount in 7/7 MEFs compared to +/+ MEFs.
Taken together, these data are consistent with IC261 leading to a p53-dependent arrest of the cells with a DNA content of 4 N. In cells with a relaxed (p53+/7 cells) or without p53 response (p537/7 cells) IC261 induced an increase in ploidy compared to p53+/+ cells. The higher DNA content is accompanied with a rise in the number of cells commited to the apoptotic pathway. Therefore, the p53-dependent arrest may protect cells from apoptosis in the presence of IC261.
IC261, like nocodazole (NOC), leads to wt p53-dependent postmitotic arrest Most drugs that induce an increase of DNA content belong to the group of spindle inhibitors. We therefore compared the eects of IC261 on cell cycle progression with that of the microtubule inhibitor nocodazole (NOC). We tested the eects of IC261 and NOC on MethAtsp53 cells, a cell line which ectopically expresses the`valine 135' temperature-sensitive p53 mutant. At 398C tsp53 is in a mutant conformation, but wild-type functions can be restored by shifting the cells from growth at 398C to 308C where a signi®cant proportion of the p53 protein is in the wild-type conformation (Otto and Deppert, 1993) . The particular advantage of this cell line is that cells continue to grow at the permissive temperature, owing to high levels of MDM2 (Knippschild et al., 1995; Otto and Deppert, 1993) .
Flow cytometry analysis of PI-stained cells showed that, both IC261 and NOC treatment gave rise to an increase in the cellular DNA content in MethAtsp53 cells when grown at 398C (Figure 2 ). Sixteen hours after drug exposure, 55% of the cells treated with 0.6 mM IC261 and 60% of cells treated with 0.4 mM NOC had an aneuploid DNA content (An) greater than 4 N. At 24 h and 48 h post-treatment, up to 90% of the cells treated with IC261 and 75% of NOC treated cells had exactly doubled their DNA to an 8 N content. As expected, we received the same result with the parental MethA cells (data not shown).
In MethAtsp53 cells shifted to 308C (Figure 2b ) drug treatment increased the 4 N population to 43% after 72 h IC261 treatment, respectively to 32% in the presence of 0.4 mM NOC. In comparison, shifting cells to 308C for Figure 1 Analysis of the eects of the CK1d/e-speci®c inhibitor IC261 on cell cycle distribution and survival of MEFs. Cultures of MEFs (passage no 2) of dierent genotypes (p53+/+, p53+/7, p537/7) were treated with the CK1d/e-speci®c kinase inhibitor IC261 in the low micromolar range (1 mM). (a) At the speci®ed time points cells were trypsinized, washed in PBS, ®xed in 70% ethanol and stained with PI (Material and methods). Flow cytometry of cells was performed on a Coulter Epics XL-MCL; calculation of cell cycle stages was done using the cell cycle analysis program WinCycle for Windows. (b) For measurement of apoptotic or necrotic eects of IC261, MEF cells were collected after dierent time points following IC261 treatment. PBS-washed cells were incubated with FITC-coupled Annexin V to detect apoptosis and afterwards stained with PI to detect necrotic cells (Material and methods). The two-parametric¯ow cytometry displays distinct populations of viable (PI7/FITC7(1)) and apoptotic (PI7/FITC+(2)) but only few necrotic (PI+/FITC+(3)) cells. Quanti®cation of the subpopulations was done using the program System II, 3.0 version (Coulter) same time periods without drug treatment only leads to a slight increase of cells with a 4 N DNA content (data not shown). Taken together, the data indicate that IC261 can produce eects on cell cycle progression that are indistinguishable from an established spindle poison and are dependent on the p53 status of the cells.
The increase of ploidy by inhibition of spindle assembly is characteristic of many cancer cell lines (Roberts et al., 1990) . In these cells the loss of spindle checkpoint control leads to the uncoupling of cytokinesis and replication resulting in 8 N or even 16 N DNA contents. Most often the increase in ploidy is accompanied by the enlargement of the cells and the development of micronuclei (Fujikawa-Yamamoto et al., 1997) . To investigate the possibility that the kinase inhibitor leads to similar postmitotic eects, we investigated the nuclear morphology of MethAtsp53 cells using combined bright®eld-¯uorescence images of Considering the generation of micronuclei over the time (Figure 3b) , it is obvious that NOC induces micronucleation to a greater extent (up to 88%) than the kinase inhibitor IC261 (up to 37%), at least at the used concentration of 0.6 mM. In MethAtsp53 cells grown at 308C both inhibitors had no eect on the amount of micronucleated cells. Thus, with respect to nuclear morphology and cell cycle distribution, the response of the MethAtsp53 cells to IC261 showed striking similarity to the response to NOC.
IC261 treatment results in a p53-independent transient mitotic arrest
The similarities in the response to the CK1d/e speci®c inhibitor IC261 and to the spindle drug NOC suggest that CK1d/e activity is required for normal mitotic passage. Spindle drugs interfere with mitotic progression by preventing the assembly of the spindle apparatus leading to a signi®cantly prolonged mitosis (Kahn et al., 1998; Lanni and Jacks, 1998) . In order to determine changes in mitotic kinetics as a result of inhibition of CK1d/e we made use of the monoclonal antibody MPM-2, which recognizes a conserved epitope shared by mitotic phosphoproteins (Davis et al., 1983) . For this purpose MEFs with dierent p53 backgrounds (p53+/+, p53+/7 and p537/7) were treated with 1 mM IC261 and analysed by twoparametric¯ow cytometry after dierent time points. Simultaneous staining of MPM-2 with a FITC-coupled IgG and DNA by PI permitted the detection of a distinct population of mitotic cells (Figure 4 ). Exposure to IC261 led to an immediate increase of a mitotic subpopulation after 6 and 12 h independently of the genetic background of dierent MEFs. As shown in the diagram in Figure 4 , all three cultures displayed a peak of MPM-2 reactivity after 12 h but MPM-2 signal decreases after 24 and 48 h. The temporary increase of MPM-2 reactivity has to be explained by a transient arrest in mitosis prior to metaphase-anaphase transition at which dephosphorylation of MPM-2 antigens takes place (Vandre and Borisy, 1989) . The similarities in changes of mitotic kinetics in MEFs with and without p53 indicate that the IC261-induced mitotic delay is independent of the p53 status of the cells. G1-like status of postmitotic arrested, wt p53 containing cells
Consistent with the published model for drugs that trigger the spindle checkpoint (Di Leonardo et al., 1997; Minn et al., 1996) , IC261 treated cells expressing functional p53 show a mitotic delay and ®nally arrest with a 4 N DNA content at the G1/S boundary. To con®rm that IC261 treated cells with active p53 arrest in G1, we investigated the cyclin A status of IC261-arrested MethAtsp53 cells, shifted to the permissive growth temperature of 308C.
Cyclin A begins to accumulate at the G1/S transition and persists through S and G2 phase. Cyclin A-associated kinase activity is required for S phase, completion of S phase and entry into mitosis, but has to be degraded to exit from mitosis (Lehner and O'Farrell, 1989; Walker and Maller, 1991) . Simultaneous staining of cyclin A-FITC and DNA with PI of untreated MethAtsp53 cells maintained at 308C revealed, as expected, that cyclin A levels increased in 4 N cells (G2 phase) in comparison to 2 N cells (G1 phase) (Figure 5a ). In contrast, 8 h after IC261 treatment, we observed a remarkable decrease of cyclin A reactivity in 4 N containing cells. At later timepoints the cyclin A antigen status of 4 N containing cells nearly matches that of G1 cells. Therefore, our data support the hypothesis that cells expressing p53 in its wild-type conformation, although containing a double set of chromosomes, arrest IC261-dependent in the postmitotic G1 phase. To con®rm this G1-like status of MethAtsp53 cells maintained at 308C we determined the phosphorylation status of the retinoblastoma protein (Rb). The phosphorylation of Rb is a key event in transition of cells at the G1/S boundary (Thomas et al., 1991) . MEFs were ®xed in 70% ethanol and stained for MPM2 and PI (Material and methods). In a two-parametric¯ow cytometry diagram a MPM-2 positive, 4N containing subpopulation were detected. The statistical analysis revealed a transitory increase of the mitotic population after IC261 treatment independent of the genotype of MEFs Figure 5 MethAtsp53 cells kept at the permissive temperature (308C) and expressing p53 in wt conformation arrest in G1 after treatment with IC261. (a) IC261 treated (8, 16, 24 h) and untreated (control) MethAtsp53 cells were maintained at 308C, ®xed in 70% ethanol and stained for cyclin A using a rabbit polyclonal antibody against cyclin A followed by incubation with a FITCcoupled anti-rabbit IgG. In addition, to simultaneously determine the cell cycle stages, cells were stained with PI. The twoparametric¯ow cytometric analysis shows an increase in cyclin A-positive, 4N containing cells by time. (b) To determine the phosphorylation status of Rb, lysates from untreated (c, f) and IC261 treated (1 mM IC261 for 48 h and 72 h) (a/d, b/e) MethAtsp53 cells grown at the permissive (a ± c) and non permissive temperature (d ± f) were subjected to SDS ± PAGE. Proteins were blotted onto nitrocellulose membranes and probed with a monoclonal anti-Rb IgG. Immunocomplexes were visualized by a HRP-coupled anti-mouse IgG and subsequent chemiluminescence detection CK1 inhibitors generate mitotic defects L Behrend et al the loss of checkpoint function of p53 in its mutant conformation.
IC261 interferes with ordered mitosis by inducing centrosome amplification and multipolar mitosis
To follow up the idea that the mitotic delay of IC261-treated cells is a result of interference with ordered mitosis we analysed mitotic cells 8 to 12 h after IC261 treatment. We collected mitotic shake o cells from the media and prepared suspended cells by cytospin. Mitotic spindles and centrosomes were analysed by immuno¯uorescence microscopy using antibodies against b-tubulin and g-tubulin, respectively. The cellular chromatin was visualized by DAPI-staining. The images presented in Figure 6a ,b show untreated C57MG cells. The metaphase cell in Figure 6a represents an ordered mitotic architecture with all chromosomes aligned at the metaphase plate displaying two spindle poles. In addition to metaphase cells we detected cells in anaphase, telophase and cytokinesis ( Figure 6b ).
The treatment of cultures with dierent concentrations of NOC interferes with an ordered mitotic architecture (Figure 6c,d ). Using 0.4 mM NOC, a concentration normally used for induction of the spindle checkpoint, absolutely suppresses the assembly of mitotic spindles (Figure 6c) . Additionally, instead of having only two centrosomes the NOC-treated cells exhibited multiple g-tubulin positive structures. In cells treated with lower concentrations of 0.1 mM NOC a small amount of tubulin is assembled in microtubule structures, but without showing a true spindle architecture (Figure 6d ). Instead, short radial orientated microtubule assemblies surround g-tubulin positive spots. At this lower concentration only the elongation of spindles, but not the nucleation of spindles from the g-tubulin-positive structures (possibly centrosomes), seems be inhibited.
In contrast to NOC-treated cells, in cells treated with 0.6 mM IC261 we observed assembled spindles (Figure 6e ± h). Analysis of mitotic cells revealed three dierent groups of cells. In the ®rst group represented by the cells shown in Figure 6e ,f we found bipolar mitosis but frequently with failures of the spindle structure. The most prominent modi®cation is the ring-shaped dispersion of pericentriolar material. In the second group we found multipolar spindle and a distribution of centrosomal structures in the entire cell (Figure 6g) . Also, in a minority of cells, we observed a regular mitotic architecture (Figure 6h ): a bipolar undisturbed spindle with two spindle poles and metaphase chromosomes regularly aligned at the metaphase plate. However, in contrast to the situation in non-treated cells, we could never detect mitotic cells treated with IC261 in anaphase or telophase arguing for a metaphase-arrest of the cells. The immuno¯uorescence images demonstrate that the IC261-induced delay in mitosis is often accompanied by alterations in mitotic architecture but generally without interference with spindle assembly.
While IC261 has strong eects on spindle architecture immuno¯uorescence microscopy of interphase cells revealed no detectable eect of IC261 on microtubule structure at concentrations speci®c for inhibition of CK1d/e (data not shown). Therefore, at the used concentration, the morphological eects of IC261 seems to be restricted to mitosis.
Discussion
The data presented in this paper show that IC261, a speci®c inhibitor of the delta and epsilon isoforms of Figure 6 IC261 and NOC induce dierential defects in the architecture of the mitotic apparatus. Untreated C57MG cells (a, b), cells treated with 0.4 mM (c) or 0.1 mM NOC (d) for 12 h and cells treated with 0.6 mM IC261 for 12 h (e ± h), respectively, were prepared for immuno¯uorescence staining by cytospin from the media (mitotic shake o cells). Cells were stained using monoclonal anti-b-tubulin followed by FITC-coupled anti-mouse IgG and polyclonal anti-g-tubulin followed by rhodamine-coupled anti-rabbit IgG, respectively. Accordingly, the spindles are visualized in green and the centrosomes are seen in red by indirect immuno¯uorescence staining. The DNA was stained in blue by DAPI protein kinase CK1 has profound eects on the progression of early passage embryo ®broblasts and of MethAtsp53, a cultured line expressing a temperature-sensitive p53 protein. Speci®cally, IC261 arrests cells expressing functional p53 in the postmitotic G1 phase, whereas cells which lack functional p53 function override the checkpoint control and undergo endoreduplication, most of them developing micronuclei. Several studies have shown that classical microtubuledisrupting or -stabilizing agents including NOC, colcemid and paclitaxel show precisely these phenotypes on p53-competent and p53-null cells (Cross et al., 1995; Di Leonardo et al., 1997; Gualberto et al., 1998; Lanni and Jacks, 1998; Minn et al., 1996; Notterman et al., 1998; Sablina et al., 1998; Wahl et al., 1996a) . Our own analyses using NOC (Figures 2 and 3) are consistent with these observations. Moreover, exposing either p53-competent or p53-defective cells to an inhibitor of CK1d/e produces eects which are strikingly similar to those of NOC interfering with ordered mitotic progression. These data are consistent with the idea that CK1d/e plays an essential role in maintaining the integrity of cell cycle progression by controlling key functions in chromosome segregation.
The role of p53 in the control of the mitotic checkpoint has been the subject of discussion over the last few years. While Cross et al. (1995) suggested a direct involvement of p53 in the mouse spindle checkpoint, more recent analyses have disproved the direct association of p53 with spindle assembly control. For example, mutants that lack components of the spindle assembly checkpoint, such as the BUB or MAD gene products ®rst identi®ed in budding yeasts (Dobles et al., 2000) , fail to accurately segregate chromosomes. In contrast p53-negative cells are still able to traverse mitosis. Moreover, the kinetics of mitotic progression in the presence of spindle inhibitors are not in¯uenced by the p53 status of the cells (Lanni and Jacks, 1998).
The current perception of the role played by p53 in responding to spindle disruption is that p53 acts in a postmitotic manner preventing damaged cells from proceeding through S phase. The data obtained from the treatment of cells with IC261 are consistent with results disproving a direct involvement of p53 in mitotic checkpoint. The quanti®cation of mitotic cells by measuring the MPM-2-status in IC261 treated p53+/+, p53+/7 and p537/7 MEFs showed that the kinetics of delayed mitosis in these cells are approximately the same. Therefore, inhibition of CK1d/e activity prolongs mitosis in a p53-independent manner. These results are consistent with a MPM-2-based¯ow cytometric assay of Khan and Wahl (1998) showing same results with NOC. The resemblance between IC261 and NOC mediated early (mitotic delay) and late eects (postmitotic G1 arrest, respectively endoreduplication) in cells with and without a mitotic checkpoint control strongly suggests that IC261 itself triggers the mitotic checkpoint.
Drugs that interfere with an ordered chromosome segregation, and therefore with cytokinesis, induces apoptosis (Woods et al., 1995) . In this study, we present that IC261 like spindle drugs induces apoptosis in both, cells with and without checkpoint activity of p53. Treatment of p53 wild-type MEFs with IC261 immediately after 24 h induces apoptosis rates near 20% that stay the same over following days. In p53-null MEFs apoptosis rates constantly rises up to the fourth day to approximately 50%. Interestingly, the extend of apoptosis at later timepoints rises in correlation with the loss of checkpoint function in the order +/+, +/7, 7/7 MEFs. Therefore, this later cell death (3 ± 5 days) seems to be reasoned in the progression beyond the G1/S postmitotic checkpoint in p53-null cells. The pronounced p53-independent apoptotic eect should turn attention on a possible therapeutic applicability of IC261 as a large fraction of human cancers are mutated in the p53 gene.
While the eects of chemotherapeutics which interfere with spindle assembly (classical spindle poisons) or stabilize microtubules (taxoids) are partly understood, the nature of interference of IC261 with mitotic progression was unknown and was therefore addressed. The investigation of the mitotic architecture of cells treated with submicromolar concentrations of IC261 or NOC respectively revealed a characteristic distinction. In contrast to NOC-treated cells, we found that the assembly of spindle microtubules stained by anti-btubulin antibodies is not generally inhibited by IC261. Nevertheless, unlike untreated mitotic cells, most IC261-treated cells showed a drastic ampli®cation of spindle poles. In addition, DAPI-staining of these cells showed fully condensed but randomly spread chromosomes; a phenotype we also found in NOC arrested cells. IC261, therefore, resembles spindle poisons that inhibit the correct positioning of chromosomes in metaphase. While the condensation of chromosomes is dispensable for an intact spindle apparatus the movement of chromosomes towards the metaphase plate is a microtubule dependent phenomenon. This supports the argument that IC261 interferes with spindle function probably by modulating the dynamics of the spindle. As we found no in¯uence of IC261 on cell shape or cytoskeleton in interphase cells and, in addition, IC261 had no eects on resting cells, we conclude that IC261 selectively interferes with microtubule dynamics during mitosis.
The eects of IC261 on cell cycle progression and apoptosis can be attributed to targeting of the spindle during an early mitotic stage. The question then arises as to whether CK1d/e is indeed the major target of IC261 and consequently what is the role of CK1d/e during mitosis? So far the precise mechanisms that regulate the rapid process of spindle assembly are unclear. In recent years a growing number of studies have underscored the important role of tubulin associated proteins in spindle dynamics, especially those of microtubule associated proteins (MAPs), catastrophe factors (reviewed in Andersen, 2000) and motor proteins (reviewed in Mountain and Compton, 2000) . The comprehensive eects of IC261 on spindle architecture before cells reach the metaphase border point to IC261 directly in¯uencing spindle dynamics. Indeed, our and the work of other groups implicate a direct connection of the CK1 family to spindle functions. As seen from immuno¯uorescence and coimmunprecipitation experiments, CK1d speci®cally associates with the spindle and the centrosomes in cells with irregular mitosis (Behrend et al., 2000) . The close vicinity to microtubules is also expressed in the substrate speci®city of CK1d. CK1d is known to phosphorylate tubulins, the microtubule associated proteins tau and MAP4 and stathmin (Behrend et al., 2000; Kuret et al., 1997; Singh et al., 1995) . Indeed we found, that inhibition of CK1d/e by IC261 changes the in vivo phosphorylation pattern of some of the mentioned in vitro substrates (StoÈ ter et al., paper in preparation) . A number of accessory proteins capable of stabilizing or destabilizing microtubule polymers are modi®ed and regulated by cell cycle-dependent phosphorylation. Through this regulation, microtubule dynamics are modi®ed to generate rapid microtubule turnover during mitosis (reviewed in Cassimeris, 1999) . We suppose that IC261 mediated intervention with spindle functions may be the result of reduced phosphorylation of spindle accessory proteins and, therefore, in¯uencing the balance between stabilizers and destabilizers.
Recently, CK1 has been connected to another group of tubulin associated proteins, the motor proteins. It has been shown that CK1 from Chlamydomonas interacts with the intermediate chain of dynein in the axonem of the¯agella (Yang and Sale, 2000) . Because the inhibition of phosphorylation of dynein by speci®c inhibitors of CK1 rescues a mutant with reduced agella rotation authors stated CK1 as a negative regulator of¯agellar movement. Dynein and members of the dynein-associated dynactin complex have been implicated in the positioning of the mitotic spindle in vivo (reviewed in Busson et al., 1998) or in the formation of the spindle in cell extracts (Palazzo et al., 1999; Walczak et al., 1998) . If the results connecting CK1 to dynein functions could be con®rmed in mammalians this would raise dynein to a possible target for IC261. The interference with dyneinmediated movements would explain the observed disturbance of the spindle apparatus. Some of these kinesin-related motor proteins are located to the spindle and/or centrosomes and display functions in the spindle organisation, the centrosome separation and positioning (Agarwal et al., 1998; Boleti et al., 1996; Gaglio et al., 1996; Sharp et al., 1999) . For example ncd is located to centrosomal microtubules and spindle ®bers and seems to be critical for poleward movement of chromosomes in mitosis. Interestingly, mutants of the Drosophila ncd microtubule motor protein cause centrosome splitting and loss of centrosomes from spindle pole (Endow et al., 1994) , much the same defects induced by IC261.
Taken together, we provide strong evidence that CK1d and e are key proteins in chromosome segregation as the speci®c inhibitor of both isoforms IC261 is intervening with mitosis and triggers p53-dependent mitotic checkpoint. We speculate here that the critical step in IC261 induced eects may be the interference with CK1d/e-speci®c phosphorylation of spindle component proteins. However, this hypothesis derived from cellular biology remains to be tested by making use of molecular genetics.
Materials and methods
Cell lines and culture medium
Primary mouse embryo ®broblast (MEF) cultures with dierent p53 background (p53 +/+, p53 +/7 and p53 7/7) were prepared from mechanically dispersed 17-day-old Balb/c mouse embryos by digestion with 0.2% collagenase in phosphate buered saline (PBS). Primary MEF cultures and C57MG cells, a mouse mammary epithelial cell line (Vaidya et al., 1978) , were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% FCS at 378C in a humidi®ed 5% CO 2 atmosphere. MethA, a methylcholanthrene-transformed ®brosarcoma cell line (DeLeo et al., 1977) and MethAtsp53 cells, obtained after transfection of MethA tumour cells with a tsp53 val135 expressing vector (Otto and Deppert, 1993) , were grown in DMEM supplemented with 5% FCS. MethAtsp53 cells were maintained at 398C and in order to express tsp53 in wild-type conformation cells were shifted to 308C.
Reagents and primary antibodies
The spindle inhibitor nocodazole (Sigma) and the kinase inhibitor IC261 (Icos Corp., Washington, USA) were solved in DMSO and stored at 7208C in 10 mM (nocodazole) and 25 mM (IC261) stock solutions.
For immunodetection we used polyclonal antibodies against g-tubulin (Sigma) and cyclin A (Santa Cruz). Additionally, monoclonal antibodies against b-tubulin (Boehringer), MPM-2 (Upstate Biotechnology) and Rb (a gift from Irene Dornreiter, Hamburg) were used.
Immunofluorescence microscopy
Cells used for immuno¯uorescence staining were grown on coverslips or prepared by cytospin in a cytospin 3 centrifuge (Shandon) at 600 r.p.m. for 6 min. Cells were washed twice in PBS and ®xed in 3% paraformaldehyde in PBS for 10 to 15 min at 378C. Fixed cells were permeabilized in PBS containing 0.3% Triton-X-100 (Fluka) for 3 min at room temperature. Fixed cells were washed in PBS and blocked in PBS containing 0.2% gelatine for at least 1 h followed by an 1 h incubation with primary antibodies. Secondary antibodies were incubated for 30 min using FITC-or Rhodaminelabelled IgG (Dianova, Germany), respectively. DNA was visualized by DAPI staining (10 min; 0.1 mg/ml). Epi¯uores-cence microscopy was performed using a Leica 636/1.4 or 406/1.0 oil immersion objective with a Leica DM-R microscope equipped with a high resolution digital camera system (Diagnostic Instruments, Intas, Germany).
Lysis, SDS ± PAGE and Western immunoblotting
Cells were washed in ice-cold PBS, extracted for 30 min with a buer containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10% glycerol, 0.5% NP40, 5 mM DTT, 1 mM EDTA, 1 mM EGTA, 50 mM leupeptin and 30 mg/ml aprotinin, cleared by centrifugation for 30 min at 15 0006g and denatured in sodium dodecyl sulfate (SDS) containing sample buer. After separation on SDS-polyacrylamide gels, proteins were transferred onto a nitrocellulose membrane (Hybond C super, Amersham Pharmacia Biotech.). The membranes were probed with speci®c antibodies. Immunocomplexes were detected using horse radish peroxidase conjugated with antimouse IgG (SAPU, GB, Scotland) followed by chemiluminescence detection (ECL, Amersham Pharmacia, Germany and Pierce, USA).
Flow cytometry
For¯ow cytometry analysis approximately 1610 6 cells were collected from 9 cm culture dishes (Nunc) and ®xed in icecold 70% ethanol following incubation for 15 min on ice and storage for at least 1 h at 7208C. To perform cell cycle analysis cells were washed in PBS and stained with a propidium iodide (PI)-solution containing 50 mg/ml PI (Sigma) and 10 mg/ml RNAse (Fluka) in PBS at 378C for 30 min. For the staining of intracellular epitops ethanol ®xed cells were washed in wash solution (0.05% Triton-X-100 in PBS) and resuspended in 100 ml staining solution (0.2% Triton-X-100 and 2% FCS in PBS), supplemented with 2.5 mg/ml of the indicated antibody and incubated for 2 h at 48C. Cells were then washed in wash solution and resuspended in staining solution with FITC-conjugated antimouse or anti-rabbit antibodies (Dianova, Germany) followed by incubation for 1 h at 48C. Epitope stained cells were subsequently stained with PI-solution.
To evaluate apoptotic and/or necrotic eects of IC261 we used a method of Vermes et al. (1995) , staining cells sequentially with FITC-coupled AnnexinV (Boehringer) and PI. This procedure permitted us to discriminate between viable cells (PI7/FITC7), apoptotic cells (PI7/FITC+) and necrotic cells (PI+/FITC+).
All indicated¯ow cytometric assays were made (with at least 10 000 cells) on a Coulter Epics XL-MCL¯ow cytometer. The quanti®cation of cell populations was performed using the DOS software System II, 3.0 version, or for analysis of cell cycle distribution, the program MultiCycle for Windows.
